Back
ProShares Ultra Nasdaq Cloud Computing Vs. Akero Therapeutics Industry Stock Comparison
Buy
57
SKYU
ProShares Ultra Nasdaq Cloud Computing
Last Price:
$32.43
Seasonality Move:
-3.57%
Sell
44
AKRO
Akero Therapeutics
Last Price:
$51.76
Seasonality Move:
45.38%
Buy
57
ProShares Ultra Nasdaq Cloud Computing (SKYU)
is a Buy
Is ProShares Ultra Nasdaq Cloud Computing a Buy, Sell or Hold?
-
The current ProShares Ultra Nasdaq Cloud Computing [SKYU] share price is $32.81. The Score for SKYU is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SKYU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.73. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKYU Stock Price Chart
What is ProShares Ultra Nasdaq Cloud Computing's stock price today?
-
The ProShares Ultra Nasdaq Cloud Computing share price today is $32.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKYU is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.73The current trend is moderately bearish and AKRO is experiencing slight buying pressure.
SKYU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.21 | Buy |
Relative Strength Index (14 RSI): | 51.98 | Buy |
Chaikin Money Flow: | 500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.47 - 33.83) | Buy |
Bollinger Bands (100): | (24.95 - 33.91) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 53.6 | Buy |
Chaikin Money Flow: | 120856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.86 - 55.26) | Sell |
Bollinger Bands (100): | (40.15 - 52.05) | Buy |
SKYU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.78 | Sell |
20-day SMA: | 32.74 | Buy |
50-day SMA: | 31.27 | Buy |
200-day SMA: | 32.5 | Buy |
8-day EMA: | 23.81 | Buy |
20-day EMA: | 13.17 | Buy |
50-day EMA: | 6.07 | Buy |
200-day EMA: | 1.64 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.62 | Buy |
20-day SMA: | 53.45 | Sell |
50-day SMA: | 49.34 | Buy |
200-day SMA: | 39.34 | Buy |
8-day EMA: | 52.09 | Buy |
20-day EMA: | 52.29 | Buy |
50-day EMA: | 49.9 | Buy |
200-day EMA: | 41.1 | Buy |
ProShares Ultra Nasdaq Cloud Computing Earnings Growth & SKYU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
ProShares Ultra Nasdaq Cloud Computing Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |